drugset / Trial / NCT01972178
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is * To evaluate the efficacy of PRC-4016 by assessment of the percentage change in blood lipids and lipoprotein parameter from baseline after 12 weeks of treatment * To evaluate the safety of PRC-4016 as assessed by adverse events and other safety parameters
Timeline
- Start
- 2013-11
- Primary completion
- 2014-07
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Icosabutate | Small molecule | 600 mg | Oral |
| Background | Atorvastatin | Small molecule | — | — |
| Background | Pravastatin | Small molecule | — | — |
| Background | Rosuvastatin | Small molecule | — | — |
| Background | Simvastatin | Small molecule | — | — |